Mimicking breast cancer-induced bone metastasis in vivo: current transplantation models and advanced humanized strategies

被引:0
|
作者
Laure Thibaudeau
Verena M. Quent
Boris M. Holzapfel
Anna V. Taubenberger
Melanie Straub
Dietmar W. Hutmacher
机构
[1] Queensland University of Technology,Regenerative Medicine Group, Institute of Health and Biomedical Innovation
[2] University Hospital Erlangen,Department of Obstetrics and Gynecology
[3] Friedrich-Alexander University Erlangen-Nuremberg,Orthopedic Center for Musculoskeletal Research
[4] University of Wuerzburg,George W Woodruff School of Mechanical Engineering
[5] Biotec TU Dresden,undefined
[6] Institute of Pathology,undefined
[7] Technical University Munich,undefined
[8] Georgia Institute of Technology,undefined
[9] Institute for Advanced Study,undefined
[10] Technical University Munich,undefined
来源
Cancer and Metastasis Reviews | 2014年 / 33卷
关键词
Bone metastasis; Breast cancer; Osteotropism; Humanized xenograft model; Tissue engineering;
D O I
暂无
中图分类号
学科分类号
摘要
Bone metastasis is a complication that occurs in 80 % of women with advanced breast cancer. Despite the prevalence of bone metastatic disease, the avenues for its clinical management are still restricted to palliative treatment options. In fact, the underlying mechanisms of breast cancer osteotropism have not yet been fully elucidated due to a lack of suitable in vivo models that are able to recapitulate the human disease. In this work, we review the current transplantation-based models to investigate breast cancer-induced bone metastasis and delineate the strengths and limitations of the use of different grafting techniques, tissue sources, and hosts. We further show that humanized xenograft models incorporating human cells or tissue grafts at the primary tumor site or the metastatic site mimic more closely the human disease. Tissue-engineered constructs are emerging as a reproducible alternative to recapitulate functional humanized tissues in these murine models. The development of advanced humanized animal models may provide better platforms to investigate the mutual interactions between human cancer cells and their microenvironment and ultimately improve the translation of preclinical drug trials to the clinic.
引用
收藏
页码:721 / 735
页数:14
相关论文
共 50 条
  • [41] The Vicious Cycle of Breast Cancer-Induced Bone Metastases, a Complex Biological and Therapeutic Target
    Alfredo Cappariello
    Mattia Capulli
    Current Molecular Biology Reports, 2018, 4 (3) : 123 - 131
  • [42] The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo
    Allocca, Gloria
    Hughes, Russell
    Wang, Ning
    Brown, Hannah K.
    Ottewell, Penelope D.
    Brown, Nicola J.
    Holen, Ingunn
    JOURNAL OF BONE ONCOLOGY, 2019, 17
  • [43] Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future
    Kohno, Norio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (01) : 18 - 23
  • [44] Treatment of breast cancer with bone metastasis: bisphosphonate treatment — current and future
    Norio Kohno
    International Journal of Clinical Oncology, 2008, 13 : 18 - 23
  • [45] In vitro models of breast cancer bone metastasis: analyzing drug resistance through the lens of the microenvironment
    Lamouline, Anais
    Bersini, Simone
    Moretti, Matteo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [46] Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study
    Baek, Yeon-Hee
    Jeon, Ha-Lim
    Oh, In-Sun
    Yang, Hyowon
    Park, Jeehye
    Shin, Ju-Young
    CANCER EPIDEMIOLOGY, 2019, 61 : 104 - 110
  • [47] In vivo validation of the functional role of MicroRNA-4638-3p in breast cancer bone metastasis
    Akshaya, R. L.
    Saranya, I.
    Salomi, G. Margaret
    Shanthi, P.
    Ilangovan, R.
    Venkataraman, P.
    Selvamurugan, N.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (02)
  • [48] In vivo validation of the functional role of MicroRNA-4638-3p in breast cancer bone metastasis
    R. L. Akshaya
    I. Saranya
    G. Margaret Salomi
    P. Shanthi
    R. Ilangovan
    P. Venkataraman
    N. Selvamurugan
    Journal of Cancer Research and Clinical Oncology, 150
  • [49] RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies
    Wu, Xiaoqiu
    Li, Fangfei
    Dang, Lei
    Liang, Chao
    Lu, Aiping
    Zhang, Ge
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [50] Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression
    Liu, Yang
    Zhang, Ran-Xi
    Yuan, Wei
    Chen, Hou-Qing
    Tian, Dong-Dong
    Li, Hao
    Jiang, Xiao
    Deng, Zhong-Liang
    Wang, Yang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (05) : 1759 - 1771